John Dobak, a life sciences serial entrepreneur in San Diego, said a new startup he’s leading has raised $2.66 million to advance a drug that is already approved to shrink varicose veins through early-stage clinical trials testing it in a new... Read more »
Surface Oncology has raised $108 million from an initial public offering to finance clinical testing of its lead cancer immunotherapy.
Cambridge, MA-based Surface priced its offering of 7.2 million shares at $15 each. The company had previously planned to sell 6... Read more »
Stay current on news from Wisconsin’s innovation community with these recent headlines:
—NorthStar Medical Radioisotopes, which is seeking to become the first U.S. company in decades to domestically produce a widely used medical radioisotope, broke ground on a new 20,000-square-foot production... Read more »
San Antonio—Easy Expunctions, a Texas startup that moved its business for expunging criminal records to San Antonio from Austin in 2016, has won a local startup pitch competition hosted by Capital Factory and Geekdom and, along with it, a $100,000... Read more »
Tucked away in Southwest Detroit, not too far from the geodesic Buckminster Fuller domes built by Jack White’s brother, sits the Detroit School of Digital Technology (DSDT).
Unlike many other tech schools, DSDT is a woman-owned organization that specializes in... Read more »
The big headlines from the American Association for Cancer Research meeting in Chicago were all about the battle over the latest lung cancer data, and for good reason. Lung cancer remains the deadliest cancer, but the Phase 3 data suggest... Read more »
We had a blast at our fourth annual Robo Madness conference in the Boston area, and we hope you did, too. The theme this year was homecoming—the idea that robotics and artificial intelligence have started to seep into our lives and... Read more »
Patients who have rickets experience a softening and weakening of their bones traced to a vitamin deficiency. In a rare, inherited form of the disease, vitamin D supplements don’t work.
Ultragenyx (NASDAQ: RARE) has received FDA approval for a drug... Read more »